Loading clinical trials...

COMPLETEDNA

Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

Mechanisms and Biological Markers During Headache Induced by Natriuretic Peptides

NCT01637662•Danish Headache Center

View on ClinicalTrials.gov

Summary

To investigate headache score and accompanying symptoms during and after infusion of the natriuretic peptides.

Eligibility

Age

18 - 40 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy volunteers
•Aged 18-40
•50-100 kg
•Fertile women must use safe contraceptives (IUD, oral contraceptives, surgical sterilisation and long lasting gestagen.

Exclusion Criteria

•Tension type headache more than once/month
•Other primary headaches
•Daily medication except contraceptives
•Drug taken within 4 times the halflife for the specific drug except contraceptives
•Pregnant or lactating women
•Exposure to radiation within the last year
•Headache within the last 24 hours before start of trial
•Hypertension
•Hypotension
•Respiratory or cardiac disease

Locations (1)

Danish Headache Center

Copenhagen, Glostrup, Denmark

Key Dates

Start Date

July 1, 2012

Primary Completion Date

January 1, 2014

Last Updated

July 29, 2015

Enrollment

ACTUAL participants

Conditions

HeadacheMigraine

Interventions

Natriuretic peptides

DRUG

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

NCT06641466

Menstrual Migraine

View study

RECRUITINGPHASE3

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713

Chronic Migraine

View study

RECRUITINGNA

Mind Body Balance for Pediatric Migraine

NCT04715685

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 29, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

Inclusion Criteria

Exclusion Criteria

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Mind Body Balance for Pediatric Migraine

Light Exposure, Migraine Outcomes, and Sleep Quality

MyVitalC: Sleep and Everyday Headache Management

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine